Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Califf's Priorities Will Reflect Both Short- And Long-Term Goals

This article was originally published in The Pink Sheet Daily

Executive Summary

Newly confirmed FDA Commissioner should not assume he'll be leaving once new president arrives, Republican-appointed predecessor says.

You may also be interested in...



Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories

In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.

FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus

Acting FDA Commissioner says he can’t envision any new major priorities that would emerge in the short-term.

FDA Mandates Need Accompanying Resources, Hamburg Says

The mandates in the FDA Safety and Innovation Act and Drug Quality and Security Act show a lot of congressional confidence in the agency, but FDA commissioner says that members also must provide resources to go with it.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS079143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel